221 related articles for article (PubMed ID: 21509762)
1. A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database*.
Yan TD; Deraco M; Elias D; Glehen O; Levine EA; Moran BJ; Morris DL; Chua TC; Piso P; Sugarbaker PH;
Cancer; 2011 May; 117(9):1855-63. PubMed ID: 21509762
[TBL] [Abstract][Full Text] [Related]
2. Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma.
Yan TD; Yoo D; Sugarbaker PH
Eur J Surg Oncol; 2006 Nov; 32(9):948-53. PubMed ID: 16806796
[TBL] [Abstract][Full Text] [Related]
3. Circulating CA125 and diffuse malignant peritoneal mesothelioma.
Baratti D; Kusamura S; Deraco M
Eur J Surg Oncol; 2009 Nov; 35(11):1198-9. PubMed ID: 19423265
[No Abstract] [Full Text] [Related]
4. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.
Feldman AL; Libutti SK; Pingpank JF; Bartlett DL; Beresnev TH; Mavroukakis SM; Steinberg SM; Liewehr DJ; Kleiner DE; Alexander HR
J Clin Oncol; 2003 Dec; 21(24):4560-7. PubMed ID: 14673042
[TBL] [Abstract][Full Text] [Related]
5. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.
Yan TD; Deraco M; Baratti D; Kusamura S; Elias D; Glehen O; Gilly FN; Levine EA; Shen P; Mohamed F; Moran BJ; Morris DL; Chua TC; Piso P; Sugarbaker PH
J Clin Oncol; 2009 Dec; 27(36):6237-42. PubMed ID: 19917862
[TBL] [Abstract][Full Text] [Related]
6. Lymph node metastases in diffuse malignant peritoneal mesothelioma.
Baratti D; Kusamura S; Cabras AD; Laterza B; Balestra MR; Deraco M
Ann Surg Oncol; 2010 Jan; 17(1):45-53. PubMed ID: 19856030
[TBL] [Abstract][Full Text] [Related]
7. Five reasons why cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy must be regarded as the new standard of care for diffuse malignant peritoneal mesotheliomia [corrected].
Sugarbaker PH
Ann Surg Oncol; 2010 Jun; 17(6):1710-2; author reply 1713-4. PubMed ID: 20354799
[No Abstract] [Full Text] [Related]
8. Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma.
Yan TD; Brun EA; Cerruto CA; Haveric N; Chang D; Sugarbaker PH
Ann Surg Oncol; 2007 Jan; 14(1):41-9. PubMed ID: 17039392
[TBL] [Abstract][Full Text] [Related]
9. Colonic invasion of malignant peritoneal mesothelioma.
Chan CC; Isomoto H; Ohnita K; Mizuta Y; Kohno S; Hayashi T
Gastrointest Endosc; 2010 Feb; 71(2):397-8; discussion 398. PubMed ID: 19913225
[No Abstract] [Full Text] [Related]
10. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
Deraco M; Nonaka D; Baratti D; Casali P; Rosai J; Younan R; Salvatore A; Cabras Ad AD; Kusamura S
Ann Surg Oncol; 2006 Feb; 13(2):229-37. PubMed ID: 16444562
[TBL] [Abstract][Full Text] [Related]
11. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Cabras AD; Dileo P; Laterza B; Deraco M
Ann Surg Oncol; 2009 Feb; 16(2):463-72. PubMed ID: 19082859
[TBL] [Abstract][Full Text] [Related]
12. Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma.
Yano H; Moran BJ; Cecil TD; Murphy EM
Eur J Surg Oncol; 2009 Sep; 35(9):980-5. PubMed ID: 18977109
[TBL] [Abstract][Full Text] [Related]
13. Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
Baratti D; Vaira M; Kusamura S; D'Amico S; Balestra MR; Cioppa T; Mingrone E; De Simone M; Deraco M
Eur J Surg Oncol; 2010 Nov; 36(11):1047-53. PubMed ID: 20832234
[TBL] [Abstract][Full Text] [Related]
14. Two-stage operative cytoreduction and intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: Operative morbidity and mortality in phase I and II trials.
Kluger MD; Taub RN; Hesdorffer M; Jin Z; Chabot JA
Eur J Surg Oncol; 2010 Oct; 36(10):997-1003. PubMed ID: 20674253
[TBL] [Abstract][Full Text] [Related]
15. Risk factors and clinicopathological study of prognostic factors in the peritoneal mesothelioma.
Tudor EC; Chua TC; Liauw W; Morris DL
Am Surg; 2010 Apr; 76(4):400-5. PubMed ID: 20420251
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study.
Brigand C; Monneuse O; Mohamed F; Sayag-Beaujard AC; Isaac S; Gilly FN; Glehen O
Ann Surg Oncol; 2006 Mar; 13(3):405-12. PubMed ID: 16485159
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal mesothelioma: current status and future directions.
Chua TC; Chong CH; Morris DL
Surg Oncol Clin N Am; 2012 Oct; 21(4):635-43. PubMed ID: 23021721
[TBL] [Abstract][Full Text] [Related]
18. [A case of malignant peritoneal mesothelioma with a good response to treatment].
Mihara N; Hachisuga T; Yamasaki S; Fukuda K; Iwasaka G; Sugimori H; Miyahara S
Gan No Rinsho; 1987 Dec; 33(15):1939-44. PubMed ID: 3430746
[TBL] [Abstract][Full Text] [Related]
19. Results of treatment of 33 patients with peritoneal mesothelioma.
Sebbag G; Yan H; Shmookler BM; Chang D; Sugarbaker PH
Br J Surg; 2000 Nov; 87(11):1587-93. PubMed ID: 11091251
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of histomorphologic parameters in diffuse malignant peritoneal mesothelioma.
Cerruto CA; Brun EA; Chang D; Sugarbaker PH
Arch Pathol Lab Med; 2006 Nov; 130(11):1654-61. PubMed ID: 17076527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
